Coda bumps up series A to $34M, lays out first 2 programs by Amirah Al Idrus Tuesday, November 5, 2019 Coda Therapeutics is adding another $15 million to the bank and detailing its first two programs: chronic neuropathic pain and focal epilepsy.
